INTEREST EXPENSE AND SUPPLEMENTAL CASH FLOW INFORMATION (Tables)

9 Months Ended

Sep. 30, 2020

Supplemental Cash Flow Information [Abstract]

Summary of Interest Expenses

Interest expense in our Condensed Consolidated Financial Statements consisted of the following components:

	Three months ended September 30,					Nine months ended September 30,
(in thousands)	2020			2019		2020		2019
Components associated with borrowings from:
U.S. Revolving Credit Facility	$	3,382		$	4,292	$	10,830	$	11,644
Last Out Term Loans - cash interest	—			3,613		6,140		7,732
Last Out Term Loans - equitized interest	5,315			—		8,031		—
Last Out Term Loans - paid-in-kind interest	—			1,024		—		5,964
	8,697			8,929		25,001		25,340
Components associated with amortization or accretion of:
U.S. Revolving Credit Facility - deferred financing fees and commitment fees	1,711			8,836		14,376		22,985
U.S. Revolving Credit Facility contingent consent fee for Amendment 16	—			5,011		—		9,686
U.S. Revolving Credit Facility - deferred ticking fee for Amendment 16	—			—		1,660		—
Last Out Term Loans - discount and financing fees	(545		)	6,445		3,183		8,514
	1,166			20,292		19,219		41,185
Other interest expense	2,340			242		5,556		909
Total interest expense	$	12,203		$	29,463	$	49,776	$	67,434

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash reporting within the Condensed Consolidated Balance Sheets that sum to the total of the same amounts in the Condensed Consolidated Statements of Cash Flows:

(in thousands)	September 30, 2020		December 31, 2019		September 30, 2019		December 31, 2018
Held by foreign entities	$	36,848	$	38,921	$	30,590	$	35,522
Held by U.S. entities	2,086		4,851		1,473		7,692
Cash and cash equivalents of continuing operations	38,934		43,772		32,063		43,214
Reinsurance reserve requirements	3,443		9,318		8,802		11,768
Restricted foreign accounts	2,752		3,851		2,480		5,297
Bank guarantee collateral	3,240		—		—		—
Restricted cash and cash equivalents	9,435		13,169		11,282		17,065
Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	48,369	$	56,941	$	43,345	$	60,279

Schedule of Restricted Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash reporting within the Condensed Consolidated Balance Sheets that sum to the total of the same amounts in the Condensed Consolidated Statements of Cash Flows:

(in thousands)	September 30, 2020		December 31, 2019		September 30, 2019		December 31, 2018
Held by foreign entities	$	36,848	$	38,921	$	30,590	$	35,522
Held by U.S. entities	2,086		4,851		1,473		7,692
Cash and cash equivalents of continuing operations	38,934		43,772		32,063		43,214
Reinsurance reserve requirements	3,443		9,318		8,802		11,768
Restricted foreign accounts	2,752		3,851		2,480		5,297
Bank guarantee collateral	3,240		—		—		—
Restricted cash and cash equivalents	9,435		13,169		11,282		17,065
Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	48,369	$	56,941	$	43,345	$	60,279

Schedule of Other Significant Noncash Transactions

The following cash activity is presented as a supplement to our Condensed Consolidated Statements of Cash Flows and is included in Net cash used in activities:

	Nine months ended September 30,
(in thousands)	2020		2019
Income tax payments, net	$	3,967	$	304
Interest payments on our U.S. Revolving Credit Facility	$	8,280	$	9,748
Interest payments on our Last Out Term Loans	6,140		4,909
Total cash paid for interest	$	14,420	$	14,657